Bimatoprost, marketed under the brand name Latisse, is approved by the Food and Drug Administration (FDA) to treat inadequate eyelashes (hypotrichosis). With regular applications along the lash line of the upper eyelid, Latisse gradually encourages growth of longer, thicker and darker eyelashes.
Not all treatments, tests and services are available at all Mayo Clinic Health System locations. Check with your preferred location in advance.